PHGE - BiomX mulls pivotal trial for antibacterial after Phase 1/2 data in cystic fibrosis
2023-11-29 07:11:39 ET
More on BiomX
- BiomX: BX004 Phage Cocktail Part 2, Phase 1b/2a Clinical Results In Cystic Fibrosis Expected Any Day
- Seeking Alpha’s Quant Rating on BiomX
- Historical earnings data for BiomX
- Financial information for BiomX
For further details see:
BiomX mulls pivotal trial for antibacterial after Phase 1/2 data in cystic fibrosis